Concizumab May Be Effective Prophylaxis for Hemophilia A or B With Inhibitors
FRIDAY, Sept. 1, 2023 (HealthDay News) — Patients with hemophilia A or B with inhibitors have a lower annualized bleeding rate with concizumab than with no prophylaxis, according to a phase 3 study published online Aug. 31 in the New England Journal …
Learn MoreGene-Tweaked Stem Cells Offer Hope Against Sickle Cell Disease
THURSDAY, Aug. 31, 2023 (HealthDay News) — A type of gene therapy that precisely “edits” a key bit of DNA might offer a new way to treat sickle cell disease — a painful inherited condition that largely strikes Black children and adults.That’s accord…
Learn MorePrognostic Factors ID’d for Stage IIIb AL Amyloidosis
THURSDAY, Aug. 24, 2023 (HealthDay News) — For patients with stage IIIb amyloid light chain (AL) amyloidosis, baseline factors predictive of treatment outcomes and survival have been identified, according to a study published online Aug. 15 in Blood …
Learn MoreSpace Travel Takes Toll on Astronauts’ Blood, Bone
WEDNESDAY, Aug. 23, 2023 (HealthDay News) — When astronauts travel to space, the experience depletes their red blood cells and bone, according to a new study. Fortunately, it appears their bodies can eventually replenish them after they’ve returned t…
Learn MoreCOVID May Help Trigger High Blood Pressure in Folks Already at Risk
MONDAY, Aug. 21, 2023 (HealthDay News) — COVID-19 patients face a markedly greater risk for developing persistently high blood pressure, even if they never had blood pressure concerns before, new research indicates.The rise in risk seen among otherwi…
Learn More¿Lloraba lágrimas de sangre Vlad el Empalador, en quien se inspiró Drácula?
VIERNES, 18 de agosto de 2023 (HealthDay News) — El príncipe del siglo XV que inspiró a Drácula, el vampiro de la literatura, quizá haya tenido problemas médicos que hicieran que llorara lágrimas de sangre, según unos investigadores que exploran este…
Learn MoreProlonged Direct Oral Anticoagulants Beneficial for Preventing Recurrent VTE
MONDAY, Aug. 21, 2023 (HealthDay News) — For patients with venous thromboembolism (VTE) continuing warfarin or direct oral anticoagulants (DOACs) beyond six months, the risk for recurrent VTE is lower with DOACs, according to a study published online…
Learn MoreDid Vlad the Impaler, Inspiration for Dracula, Shed Tears of Blood?
FRIDAY, Aug. 18, 2023 (HealthDay News) – The 15th century prince who inspired the literary vampire Dracula may have had medical issues that caused him to cry tears of blood, according to researchers unearthing this ancient mystery.The prince, who was …
Learn MoreImproved Outcomes Seen With Lower 2021 KDIGO BP Target
THURSDAY, Aug. 17, 2023 (HealthDay News) — The newly lowered Kidney Disease: Improving Global Outcomes (KDIGO) blood pressure (BP) target systolic BP (SBP) of
Learn More